You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

 

Online download statistics by month:

Online download statistics by month: July 2021 to July 2025

AbstractFullPdf
Jul 2021548549198
Aug 202137437696
Sep 202114614652
Oct 2021909029
Nov 20219799121
Dec 2021737326
Jan 2022575822
Feb 2022444414
Mar 202210410836
Apr 2022646720
May 2022555519
Jun 2022606115
Jul 2022676721
Aug 2022626326
Sep 2022454520
Oct 2022596238
Nov 2022515124
Dec 2022353512
Jan 2023383813
Feb 2023616113
Mar 2023293031
Apr 2023222231
May 2023252530
Jun 2023293024
Jul 2023737316
Aug 2023232316
Sep 202320207
Oct 2023262619
Nov 2023292911
Dec 2023212112
Jan 2024353621
Feb 2024242419
Mar 2024222257
Apr 2024232324
May 2024222222
Jun 2024414023
Jul 2024495019
Aug 2024323320
Sep 2024293016
Oct 2024414224
Nov 202441426
Dec 2024404113
Jan 2025292920
Feb 2025292921
Mar 2025343418
Apr 2025444420
May 2025383921
Jun 202530309
Jul 2025220
Total303230591385